Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11655303 Anti-CD39 antibody compositions and methods

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Surface Oncology

0

Current Assignee

Surface Oncology

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

May 23, 2023

0

Patent Application Number

170212230

Date Filed

September 15, 2020

0

Patent Citations

US Patent 8728474 Immunopotentiative composition

0

US Patent 8779105 Monoclonal antibodies to programmed death 1 (PD-1)

0

US Patent 8796284 4-aminopyrimidine derivatives and their as as adenosine A

0

US Patent 8900587 Antibodies to human programmed death receptor PD-1

0

US Patent 8952136 Antibodies to human programmed death receptor PD-1

0

US Patent 9073994 Immunopotentiative composition

0

US Patent 9133197 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments

0

US Patent 10793637 Antibodies that bind CD39 and uses thereof

0

...

Patent Primary Examiner

Jeffrey Stucker

0

CPC Code

0

0

0

0

0

0

0

The invention provides anti-CD39 antibody compositions and their use in treating cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11655303 Anti-CD39 antibody compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool